Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
about
Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancerDirect non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapySTRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation markerAntimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells.Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinomaDesign of a Carbonic Anhydrase IX Active-Site Mimic To Screen Inhibitors for Possible Anticancer Properties † ‡Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosaA pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.Cellular memory of hypoxia elicits neuroblastoma metastasis and enables invasion by non-aggressive neighbouring cells.Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors.Carbonic anhydrase (Nce103p): an essential biosynthetic enzyme for growth of Saccharomyces cerevisiae at atmospheric carbon dioxide pressure.Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancerCarbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline.Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancerMetabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography.Imaging hypoxia in gliomas.Optimization of a novel peptide ligand targeting human carbonic anhydrase IXGLUT-1 expression is largely unrelated to both hypoxia and the Warburg phenotype in squamous cell carcinomas of the vulva.Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells.Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cellsImpacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in TaiwanA lactate shuttle system between tumour and stromal cells is associated with poor prognosis in prostate cancerExpression of carbonic anhydrase 9 at the invasion front of gastric cancersBetulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells.Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant NeoplasiaRegulation and function of aquaporin-1 in glioma cells.The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX ExpressionCirculating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast CancerAlternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotypeInsights towards sulfonamide drug specificity in α-carbonic anhydrasesRole of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.Estrogen acidifies vaginal pH by up-regulation of proton secretion via the apical membrane of vaginal-ectocervical epithelial cellsThe key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.Hypoxia in microscopic tumors.Carbonic anhydrase IX and renal cell carcinoma: prognosis, response to systemic therapy, and future vaccine strategies.The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder.Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
P2860
Q24300118-ACA03BEF-60AA-486C-8A1F-9421E8EE15B0Q24653348-01928240-C0A4-4F86-9D82-A8556915893BQ24673459-8C953D67-5E72-4B99-9007-0F625E91EE37Q24816725-A2D25E6C-E919-400C-8B6A-0E56DD233AE8Q26752515-AECEBB5D-420A-4816-89D4-169812AAD858Q27653519-04FDF71F-51E4-45FC-85BC-0B4AD055D150Q28246673-3837C4F2-27F4-440E-A3CC-775DB99E785BQ30317585-DDD87776-03A5-4941-988E-58D56889B656Q30621028-B437433A-370A-4E54-BE28-F874C2B25CD3Q30985593-744570AA-8CCB-4996-8C2A-C03567C859CDQ33433533-59E61CE9-42B0-4E5F-8A4B-62BEB56F5135Q33484460-D7879B98-0FD1-499D-BFC3-58A2A7B39800Q33759404-FEAF0D9D-DBD3-40B2-8794-22C63D38D1B5Q33790591-FB75C4E7-0BAE-4C97-BA89-3E58C5AD267EQ33898862-41C13BAB-B94F-4A63-A750-CC2EA1264487Q33936624-F82E30BC-5726-4D39-B6ED-DDFCBC78CDD8Q34203937-50B81288-404C-41B2-8D4F-05B0C6ED679FQ34302457-950825BC-7570-4971-9586-15CD69CB86F7Q34410669-CA7C70A6-CA49-4E9E-81E8-50145D6ED8FFQ34459093-E0D679D2-4349-4A09-BBED-126F051F041AQ34756174-BCAEBE0E-4070-4F17-87D2-8B09669E964EQ34963089-C3336331-A242-43F1-B801-00D9EF2B72EAQ35070536-ED7FBB7E-E59D-4810-A6CE-C2D6848A67C5Q35179116-8DA40CEE-F57C-4E44-BC53-8ED3C8EC5CD0Q35597597-4A6D3274-1024-4504-8747-3E855FF83F19Q35833369-C77E0750-7EC8-4351-AE79-B2E526D83226Q35926074-16800240-EC87-4FA8-A414-CA32223AABF5Q35932515-30F49648-7B09-4082-AE8C-902DD5201750Q36012580-B4BA25A0-E437-450C-86E7-6EF4D1D65A3BQ36134768-D98CB20A-0935-48F5-BD82-C42B2DDDAE81Q36569050-8FE6A267-A2E2-4ACB-B36E-835D5EDB7E88Q36608750-19C7162F-27D6-4FB8-83C8-01102B043154Q36673491-4EB13017-7185-4F34-88CA-3C14A5A7C353Q36680692-AEFB0D1E-F9D8-452B-A88E-EAA31526CC83Q36681330-CD0BA030-795E-4BA3-9012-38F528282779Q37081132-8E2BE762-6E29-44CB-B3D9-AD6B6E3BB2B3Q37126963-CC63AB6D-3F67-4741-BCBC-6FD6263F3BABQ37145167-854DB4B7-E1F7-491A-8B02-660205FD4C3FQ37145181-C3C5F4A8-F931-40F4-AEAE-9E6A2E03A6EAQ37187360-154B38CC-56D4-421D-BC31-FABB9C060249
P2860
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
@ast
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
@en
type
label
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
@ast
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
@en
prefLabel
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
@ast
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
@en
P2860
P921
P356
P1476
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.
@en
P2093
A L Harris
C P S Potter
P2860
P2888
P356
10.1038/SJ.BJC.6600936
P407
P577
2003-07-01T00:00:00Z
2003-07-07T00:00:00Z
P5875
P6179
1042703843